NCT03011593

Effect of UGIR in Adults With Compromised Gut Function and Malabsorption

Effect of UGIR on Quality of Life in Adults With Compromised Gut Function and Malabsorption

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Metagenics, Inc. · Industry
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study assessed the effect of a nutrition support product on quality of life in adults with compromised gut function and malabsorption.

Detailed description

This prospective, non-randomized, open-label study assessed the effect of a nutrition support product on quality of life in adults with compromised gut function and malabsorption. Adults with irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) or celiac disease were enrolled in the study and asked to take the study product for 6 weeks. The primary measure of the study was a validated quality of life questionnaire, the Gastrointestinal Quality of Life Index (GIQLI). Secondary measures included the Inflammatory Bowel Disease Questionnaire (IBDQ), the Celiac Disease Questionnaire (CDQ), and the Digestive Symptom Frequency Questionnaire (DSFQ).

Conditions

• Irritable Bowel Syndrome
• Crohn Disease
• Ulcerative Colitis
• Celiac Disease

Interventions

Type	Name	Description
OTHER	Nutrition Support Product	Nutrition support product contains macronutrients, micronutrients, glutamine, and prebiotics. Product is in powder form (41 grams per serving) and is mixed with water or juice before consumption. Taken orally as a nutritional shake twice per day.

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-06-01
• Completion: 2016-06-01
• First posted: 2017-01-05
• Last updated: 2022-04-06